STATORVIN Trademark

Trademark Overview

On Monday, May 5, 2014, a trademark application was filed for STATORVIN with the United States Patent and Trademark Office. The USPTO has given the STATORVIN trademark a serial number of 86271893. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 13, 2023. This trademark is owned by Cumberland Pharmaceuticals Inc.. The STATORVIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for use in the prevention and treatment of cardiovascular disease or cardiovascular complications
statorvin

General Information

Serial Number86271893
Word MarkSTATORVIN
Filing DateMonday, May 5, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 13, 2023
Registration Number4989128
Registration DateTuesday, June 28, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 23, 2014

Trademark Statements

Goods and ServicesPharmaceutical products and preparations for use in the prevention and treatment of cardiovascular disease or cardiovascular complications

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 13, 2023
Primary Code005
First Use Anywhere DateThursday, December 17, 2015
First Use In Commerce DateThursday, December 17, 2015

Trademark Owner History

Party NameCumberland Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203
Party NameCumberland Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNashville, TN 37203
Party NameCumberland Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Trademark Events

Event DateEvent Description
Friday, January 13, 2023CANCELLED SEC. 8 (6-YR)
Friday, April 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 28, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 28, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, May 24, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, May 21, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, May 14, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, May 9, 2016USE AMENDMENT FILED
Monday, May 9, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, October 20, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 19, 2015SOU EXTENSION 2 GRANTED
Thursday, October 15, 2015SOU EXTENSION 2 FILED
Thursday, October 15, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 22, 2015SOU EXTENSION 1 GRANTED
Monday, May 18, 2015SOU EXTENSION 1 FILED
Monday, June 15, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 18, 2015TEAS EXTENSION RECEIVED
Tuesday, November 18, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 23, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 23, 2014PUBLISHED FOR OPPOSITION
Wednesday, September 3, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 19, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 19, 2014ASSIGNED TO EXAMINER
Friday, May 16, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 8, 2014NEW APPLICATION ENTERED

Related Keywords

statorvin cardiovascular disease complications treatment prevention products preparations pharmaceutical